NCT04208919View on ClinicalTrials.gov

Delayed Infusion of DCreg in Living Donor Liver Transplantation

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 18, 2019

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Living Donor Liver Transplantation
Interventions
BIOLOGICAL

Donor-derived DCreg

Regulatory dendritic cells that were prepared from a donor leukapheresis will be infused into liver transplant recipients 7 days prior to the start of immunosuppression weaning.

Trial Locations (1)

15213

UPMC, Pittsburgh

All Listed Sponsors
lead

Angus W. Thomson PhD DSc

OTHER